APAC CRO MARKET
Get instant access to latest e-book

latest newsRead more...

17

Jan 2019

Phoenix Molecular Designs Announces Collaboration To Develop Diagnostic for Triple-Negative Breast Cancer

Phoenix Molecular Designs a privatelyheld biotechnology company designing precise cancer therapeutics by targeting essential kinases announced that it has entered into a collaboration with Roche to develop a diagnostic CDx in triplenegative breast cancer TNBC The Roche CDx identifies RSK activation in human tumors In…

17

Jan 2019

Luye Pharma Reaches Strategic Partnership with AstraZeneca, Strengthens Commitment to Cardiovascular Therapeutic Field

Luye Pharma has announced it has entered an agreement with AstraZeneca China the terms of which grant AstraZeneca China exclusive rights to promote Luye Pharmas Xuezhikang Capsules in mainland China This is the first time that a multinational pharmaceutical company has gained exclusive authorization in…

16

Jan 2019

Ascletis and Alphamab Announce Strategic Collaboration and Licensing Agreement for Anti-PD-L1 to Treat Hepatitis B and Other Viral Diseases

Ascletis Pharma Inc and Suzhou Alphamab Co Ltd Alphamab jointly announce today that Ascletis subsidiary and Alphamab have entered into a strategic collaboration and exclusive licensing agreement for antiPDL KN to treat hepatitis B and other viral diseases in Greater China Ascletis code ASC KN…

16

Jan 2019

Bioharmony Therapeutics and Boehringer Ingelheim Collaborate to Advance Bacteriophage Lysin Therapeutics

Bioharmony Therapeutics Inc a biopharmaceutical company focusing on the development of novel therapeutics for hard to treat bacterial infections announced today that it has entered into a Collaborative Research and Licensing Agreement with Boehringer Ingelheim to develop bacteriophage lysins for the treatment of multidrug resistant…

11

Jan 2019

Amarantus Announces Commercialization Partnership With IDEA Pharma for Subsidiaries

Amarantus Bioscience Holdings Inc a USbased JLABSalumnus biotechnology holding company developing firstinclass orphan neurologic regenerative medicine and ophthalmic therapies and diagnostics through its subsidiaries and IDEA Pharma Ltd a UKbased pathtomarket strategy and applied innovation consulting group have announced a highly original partnership to bring…

press releasesRead more...

17

Jan 2019

BlueRock Therapeutics Establishes Key Partnerships with Leading Experts in Autoimmune Disease

BlueRock Therapeutics LP an engineered cell therapy company leveraging its novel CellGene platform to develop regenerative medicines for intractable diseases today announced the establishment of partnerships with Bruce Blazar MD…

17

Jan 2019

Therachon is Granted Orphan Drug Designation by US FDA for Apraglutide for the Treatment of Short Bowel Syndrome

Therachon AG Therachon a clinicalstage biotechnology company focused on the discovery development and commercialization of innovative treatments for serious rare conditions today announced that the US Food and Drug Administration…

17

Jan 2019

Middle East IVF market worth US$1 billion as infertility rates rise to 15% in the region

The latest research by Colliers International has revealed the current global In Vitro Fertilization IVF market is estimated to be between US billion to US billion while the current IVF…

17

Jan 2019

Lack of regional research into precision medicine may hinder targeted therapies for cancers in the UAE

Ahead of the upcoming MEDLAB Exhibition Congress the MENA regions largest medical laboratory event experts are highlighting the need for advancing genetic and disease research in the Arab world in…

16

Jan 2019

Ironwood Pharmaceuticals Announces Approval of LINZESS® (linaclotide) in China for the Treatment of Adults with IBS-C

Zambon SpA an international pharmaceutical company strongly committed to the central nervous system CNS therapeutic area and Valeo Pharma Inc a specialty pharmaceutical company dedicated to commercializing innovative prescription products…

EventsRead more...

21-22

Jan 2019

Pharmaceutical Microbiology UK

SMI GROUP
London, United Kingdom

21-22

Jan 2019

Social Media in the Pharmaceutical Industry

SMI Group
Holiday Inn London - Kensington Forum

21-22

Jan 2019

Pharmaceutical Microbiology

SMI Group
Copthorne Tara Hotel

22-23

Jan 2019

14th Biosimilars Summit

CBI
The Hilton Alexandria Old Town

TOP ARTICLES

  • 4

    Are you Ready for EU FMD?

    With the deadline looming for enactment of EU FMD and US DSCSA Vikash Pushpraj Senior Vice President rfxcel explains how achieving compliance is about much more..
  • 6

    Cancer Stem Cell (CSC) Inhibitors

    Cancer as a group of heterogeneous diseases very well known Unimaginable amounts of money and manhours have been spent in finding cure for this deadly disease H..

Knowledge Bank

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia
    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot..

  • Articles

    MicroRNA (miRNA) in Nanostructure Lipid Carriers based Tumor Gene Therapy

    Introduction MicroRNAs is a noncoded double stranded RNAs made of approximately of nucleotides disclosed in by Ambros and Ruvkun laboratories that has significant role in regulation of gene expression at post transcriptional level It has been identified that the noncoding region of mRNA is capable of providing targeting signals in RNA binding protein domain…

  • Techno Trends

    NRX-101 Represents New Class of Antidepressants to Decrease Suicidal Thoughts

    NeuroRxs NRX the first oral drug targeting suicidal bipolar depression helps to treat severe bipolar depression with Acute Suicidal Ideation Behavior ASIB NRX is used for treatment of Severe Bipolar Depression with Acute Suicidal Ideation Behaviour after initial stabilisation with ketamine or other effective therapy NRX Dcycloserinelurasidone fixed dose combination is the first oral drug demonstrated in human volunteers to…

Editorial Section

  • Strategy

    Statin Drug Interactions and Related Adverse Reactions

    Statins are generally well tolerated with a low frequency of adverse events but since statins are prescribed on a longterm basis many patients will typically receive pharmacological therapy for concomitant conditions during the course of statin treatment and potentially interacting…

  • Research development

    Stem Cell and Gene Delivery

    These days gene and stem cell therapies have the potential to make the substantial impact on the treatment of several diseases However there are pros and cons of each strategy but the optimal selection of gene delivery vector or stem…

  • Clinical Trials

    ManagingClinical TrialAgreements

    Clinical Trial Agreements set out how a clinical trial will be run at the site and are an essential GCP document There are a number of key factors that determine whether a Clinical Trial Agreement is successful in achieving that…

  • Information Technology

    R&D DATA HUB

    Faster decision making and better trial oversight at all levels requires truly next generation data integration and analytics Source and format agnostic data aggregation aided by modern data lake architecture and advanced analytics deliver interactive…

TOP